Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheet (Unaudited)

v3.20.2
Condensed Balance Sheet (Unaudited)
Mar. 31, 2020
USD ($)
ASSETS  
Deferred offering costs $ 74,074
TOTAL ASSETS 74,074
Current liabilities  
Accrued expenses 1,000
Accrued offering costs 30,000
Promissory note — Related party 19,074
Total Current Liabilities 50,074
Stockholders’ Equity  
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Additional paid-in capital 24,123
Accumulated deficit (1,000)
Total Stockholders’ Equity 24,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 74,074
Class A common stock  
Stockholders’ Equity  
Common stock value
Class B common stock  
Stockholders’ Equity  
Common stock value 877 [1]
Total Stockholders’ Equity $ 877
[1] Included up to 1,143,750 shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. On May 28, 2020, the Company effected a 1:1.25 stock split with respect to the Class B common stock, on June 24, 2020, the Company effected a 1:1.20 stock split with respect to the Class B common stock and on June 25, 2020, the Company effected a 1:1.01666 stock split with respect to the Class B common stock, resulting in the Sponsor holding an aggregate of 8,768,750 Founder Shares (see Note 5).In connection with the underwriters' partial exercise of the over-allotment option and the forfeiture of the remaining over-allotment option, 18,750 Founder Shares were forfeited and 1,125,000 Founder Shares are no longer subject to forfeiture. As a result, at June 30, 2020, there are 8,750,000 Founder Shares outstanding.